Cite
HARVARD Citation
Kavanaugh, A. et al. (n.d.). AB0450 Effect of adalimumab discontinuation on patient-reported outcomes and work productivity in early rheumatoid arthritis patients who achieved low disease activity following 26 weeks of treatment: Data from the optima study. Annals of the rheumatic diseases. p. 663. [Online].